Clinical Trial Update: A Study of SIPLIZUMAB in AILD and LT Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of SIPLIZUMAB for autoimmune liver disease and liver transplant-related conditions is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis
• Autoimmune Liver Disease
• Cirrhosis of the Liver
• End-stage Liver Disease
• Sclerosing Cholangitis

Drugs mentioned

• Siplizumab (siplizumab)

Snippet

Sponsor: Elizabeth C. Verna | Conditions: Autoimmune Liver Disease, Liver Transplant Disorder | Phase 1 | Status: RECRUITING